‘Black Fungus’- An alarming infection during novel coronavirus- A Review

Abstract

Mucormycosis is a most emerging angioinvasive fungal infection of filamentous fungi of zygomycetes class, which on neglecting, causes severe disseminated infection along with significant chances of morbidity and mortality. The diagnosis and treatment remain a bit of a challenging case for the doctors. It has been seen that people who have been suffering from different diseases, such as hematological malignancies, uncontrolled diabetes, or gone through different surgeries, such as hematopoietic stem cell transplant, solid transplantation, are the ones affected by the most. On the other hand, people who have recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) typically show the symptoms of mucormycosis after (1-2) weeks of successful recovery. Standard treatment of mucormycosis is traditionally considered an amphotericin B intravenous (IV) drug as initial therapy, although posaconazole and isavuconazole are also used. The core objective of the review is to typically focus on the area of the sudden cause of effecting mucormycosis on the patients who have already recovered from SARS-CoV-2.